Topical treatments in acne vulgaris
Malcolm, B.
Practitioner 242(1585): 300-301
1998
ISSN/ISBN: 0032-6518 PMID: 10492988 Document Number: 484742
Document emailed within 1 workday
Related Documents
Stein Gold, L. 2015: Topical Treatments in Acne Vulgaris: Guidance for the Busy Dermatologist Journal of Drugs in Dermatology: Jdd 14(6): 567-572Bikowski, J. 2007: A new approach to comparing efficacy results from clinical trials of topical acne vulgaris treatments Journal of Drugs in Dermatology: Jdd 6(7): 688-692
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Adişen, E.; Kaymak, Y.şi.; Gurer, M.A.; Durukan, E. 2008: Topical tetracycline in the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 7(10): 953-955
Anderson, D.N.; Callender, V.D.; Del Rosso, J.Q.; Tanghetti, E.A.; Zane, L.T. 2004: Topical tazarotene in acne vulgaris: treatment approaches Cutis 74(4 Suppl): 16-21
Stein Gold, L.; Baldwin, H.E.; Lin, T. 2017: Management of Severe Acne Vulgaris with Topical Therapy Journal of Drugs in Dermatology: Jdd 16(11): 1134-1138
Del Rosso, J.Q.; Tanghetti, E. 2013: A status report on topical tazarotene in the management of acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): S53-S58
Zeichner, J.A. 2012: Optimizing topical combination therapy for the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 11(3): 313-317
Knutson, D.D.; Swinyer, L.J.; Smoot, W.H. 1981: Meclocycline sulfosalicylate. Topical antibiotic agent for the treatment of acne vulgaris Cutis 27(2): 203-204; 208-210
Elsaie, M.L.; Abdelhamid, M.F.; Elsaaiee, L.T.; Emam, H.M. 2009: The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 8(4): 358-364
Del Rosso, J.Q. 2007: Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy Journal of Drugs in Dermatology: Jdd 6(2): 148-151
Borglund, E.; Johannesson, A. 1979: Current topical treatment of acne vulgaris with vitamin A acid and benzoyl peroxide Lakartidningen 76(11): 978-981
Del Rosso, J.Q. 2007: Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris Journal of Drugs in Dermatology: Jdd 6(6): 616-622
Dhawan, S.S. 2009: Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris Cutis 83(5): 265-272
Biswas, S.; Mondal, K.K.; Dutta, R.N.; Sarkar, D.K. 2009: Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade i acne vulgaris Journal of the Indian Medical Association 107(4): 219-222
Taylor, S.C.; Cook-Bolden, F.E.; McMichael, A.; Downie, J.B.; Rodriguez, D.A.; Alexis, A.F.; Callender, V.D.; Alvandi, N. 2018: Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype Journal of drugs in dermatology: JDD 17(2): 160-167
Eichenfield, L.F.; Draelos, Z.; Lucky, A.W.; Hebert, A.A.; Sugarman, J.; Stein Gold, L.; Rudisill, D.; Liu, H.; Manna, V. 2013: Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides Journal of Drugs in Dermatology: Jdd 12(6): 611-618
Chien, A. 2018: Retinoids in Acne Management: Review of Current Understanding, Future Considerations, and Focus on Topical Treatments Journal of Drugs in Dermatology: Jdd 17(12): S51-S55
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429